Status:
COMPLETED
The Role of Stress Neuromodulators in Decision Making Under Risk and Selective Attention to Threat
Lead Sponsor:
Charite University, Berlin, Germany
Conditions:
Yohimbine
Hydrocortisone
Eligibility:
MALE
18-35 years
Phase:
NA
Brief Summary
Incidental affective states, i.e., affective states can influence decision making and selective attention to threatening information. Acute stress is such an affective state and is a powerful contextu...
Eligibility Criteria
Inclusion
- Right-handed
- High-school diploma
Exclusion
- Former and present DSM-5 axis I disorders according to the Structured Clinical Interview for DSM (SCID)
- Permanent medication of any kind
- Medical conditions associated with adrenal dysfunction or well-known impact on HPA activity or cognitive function
- Steroid use
Key Trial Info
Start Date :
November 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 22 2021
Estimated Enrollment :
167 Patients enrolled
Trial Details
Trial ID
NCT04359147
Start Date
November 1 2019
End Date
December 22 2021
Last Update
March 15 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Charite University
Berlin, Germany